Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Noga Gershon, Yakir Berchenko, Peter S. Hall, Daniel A. Goldstein

ABSTRACT

Background: Breast cancer is the second most common cancer worldwide, the most common among women, and the most frequent cause of death among women in less developed regions. Trastuzumab is a humanized monoclonal antibody that downregulates the extracellular domain of the HER2 protein. Using trastuzumab to treat women with localized HER2-positive breast cancer has been shown to improve survival. The objective of this study is to explore the cost-effectiveness of adjuvant trastuzumab, from a societal perspective, in 11 African countries. In addition, we aimed to establish value-based prices for trastuzumab based on the gross domestic product per capita in each country. Methods: We developed a Markov model in order to assess the costs and benefits associated with trastuzumab treatment over a lifetime horizon. A probabilistic sensitivity analysis was performed in order to estimate the impact of uncertainty of parameter-values on the results. Efficacy inputs were derived using clinical trial data from non-African countries. Results: In the base case analysis, trastuzumab yielded a gain ranging from 0.92 LYs in Nigeria to 1.07 LYs in South Africa, and 0.9 QALYs in Nigeria to 1.02 QALYs in South Africa. The incremental cost ranged from 19,561 USD in Nigeria to 19,997 USD in Congo, and an incremental cost-effectiveness ratio ranging from 19,534 USD/QALY in South Africa to 21,697 USD/QALY in Nigeria. Using willingness to pay estimates based on World Health Organization recommendations, trastuzumab appear to not be cost-effective in all countries analyzed. Cost-effectiveness estimates were most sensitive to the discount rate, trastuzumab cost, and the hazard ratio. Conclusions: Trastuzumab does not appear to be cost effective in the African countries analyzed. In order for trastuzumab to be cost-effective, the costs of treatment would require significant discounts. More... »

PAGES

5

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12962-019-0174-7

DOI

http://dx.doi.org/10.1186/s12962-019-0174-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112461724

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30867655


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ben-Gurion University of the Negev", 
          "id": "https://www.grid.ac/institutes/grid.7489.2", 
          "name": [
            "Ben-Gurion University of the Negev, P.O.B. 653, 8410501, Beer-Sheva, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gershon", 
        "givenName": "Noga", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ben-Gurion University of the Negev", 
          "id": "https://www.grid.ac/institutes/grid.7489.2", 
          "name": [
            "Ben-Gurion University of the Negev, P.O.B. 653, 8410501, Beer-Sheva, Israel"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berchenko", 
        "givenName": "Yakir", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Western General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417068.c", 
          "name": [
            "Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hall", 
        "givenName": "Peter S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of North Carolina System", 
          "id": "https://www.grid.ac/institutes/grid.410711.2", 
          "name": [
            "Davidoff Cancer Center, Rabin Medical Center, Petach Tikvah, Israel", 
            "Department of Health Policy and Management, University of North Carolina, Chapel Hill, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldstein", 
        "givenName": "Daniel A.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/cncr.22806", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002193019"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(07)60028-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002898249"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00019053-200725050-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003711819", 
          "https://doi.org/10.2165/00019053-200725050-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jgo.2016.004945", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004733479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11588340-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011962935", 
          "https://doi.org/10.2165/11588340-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.1611", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013648680"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014794593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014794593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm488", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016825538"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s0266462315000094", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018482864"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.06.3081", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018859926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.29210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018963471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.06.4220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019914471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(01)00267-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019983042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(11)70033-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021985398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.4091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024439769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/02841860601096841", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025960991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm185", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031056137"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2016.02.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031786311"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.4577", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036202282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70482-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038280023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13696998.2016.1185013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041930821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2016.09.821", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043954092"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.breast.2014.06.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048566187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70472-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052501236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jgo.2015.003079", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204594"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1590/s1135-57272004000300012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068110095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2471/blt.15.164418", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070838422"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5539/gjhs.v7n1p98", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072947815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7705/biomedica.v33i3.832", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073857235"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078418950", 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13027-017-0124-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083812371", 
          "https://doi.org/10.1186/s13027-017-0124-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13027-017-0124-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083812371", 
          "https://doi.org/10.1186/s13027-017-0124-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jgo.2016.006072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083942084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18773/austprescr.2017.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084374293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jgo.2016.008672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085401969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jgo.2016.008672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085401969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jgo.2016.008672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085401969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-017-0557-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091117104", 
          "https://doi.org/10.1007/s40273-017-0557-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-017-0557-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091117104", 
          "https://doi.org/10.1007/s40273-017-0557-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.16985", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092572143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.12688/gatesopenres.12786.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100468989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.12688/gatesopenres.12786.1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100468989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12905-018-0531-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101044352", 
          "https://doi.org/10.1186/s12905-018-0531-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaoncol.2018.1380", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104331312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2018.36.15_suppl.506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106715249"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "Background: Breast cancer is the second most common cancer worldwide, the most common among women, and the most frequent cause of death among women in less developed regions. Trastuzumab is a humanized monoclonal antibody that downregulates the extracellular domain of the HER2 protein. Using trastuzumab to treat women with localized HER2-positive breast cancer has been shown to improve survival. The objective of this study is to explore the cost-effectiveness of adjuvant trastuzumab, from a societal perspective, in 11 African countries. In addition, we aimed to establish value-based prices for trastuzumab based on the gross domestic product per capita in each country.\nMethods: We developed a Markov model in order to assess the costs and benefits associated with trastuzumab treatment over a lifetime horizon. A probabilistic sensitivity analysis was performed in order to estimate the impact of uncertainty of parameter-values on the results. Efficacy inputs were derived using clinical trial data from non-African countries.\nResults: In the base case analysis, trastuzumab yielded a gain ranging from 0.92 LYs in Nigeria to 1.07 LYs in South Africa, and 0.9 QALYs in Nigeria to 1.02 QALYs in South Africa. The incremental cost ranged from 19,561 USD in Nigeria to 19,997 USD in Congo, and an incremental cost-effectiveness ratio ranging from 19,534 USD/QALY in South Africa to 21,697 USD/QALY in Nigeria. Using willingness to pay estimates based on World Health Organization recommendations, trastuzumab appear to not be cost-effective in all countries analyzed. Cost-effectiveness estimates were most sensitive to the discount rate, trastuzumab cost, and the hazard ratio.\nConclusions: Trastuzumab does not appear to be cost effective in the African countries analyzed. In order for trastuzumab to be cost-effective, the costs of treatment would require significant discounts.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12962-019-0174-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032048", 
        "issn": [
          "1478-7547"
        ], 
        "name": "Cost Effectiveness and Resource Allocation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer", 
    "pagination": "5", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "895c986a331129a899509a6ba509a427fa8dc5b52e7f4d087fcdd50bce8e7c7b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30867655"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101170476"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12962-019-0174-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112461724"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12962-019-0174-7", 
      "https://app.dimensions.ai/details/publication/pub.1112461724"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78959_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12962-019-0174-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12962-019-0174-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12962-019-0174-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12962-019-0174-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12962-019-0174-7'


 

This table displays all metadata directly associated to this object as RDF triples.

216 TRIPLES      21 PREDICATES      69 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12962-019-0174-7 schema:about anzsrc-for:14
2 anzsrc-for:1402
3 schema:author N3d8e022d53fe426bb4f354e3e8b8e692
4 schema:citation sg:pub.10.1007/s40273-017-0557-6
5 sg:pub.10.1186/s12905-018-0531-2
6 sg:pub.10.1186/s13027-017-0124-y
7 sg:pub.10.2165/00019053-200725050-00006
8 sg:pub.10.2165/11588340-000000000-00000
9 https://app.dimensions.ai/details/publication/pub.1078418950
10 https://doi.org/10.1001/jamaoncol.2018.1380
11 https://doi.org/10.1002/cncr.22806
12 https://doi.org/10.1002/ijc.29210
13 https://doi.org/10.1016/j.breast.2014.06.006
14 https://doi.org/10.1016/j.jval.2016.02.017
15 https://doi.org/10.1016/j.jval.2016.09.821
16 https://doi.org/10.1016/s0140-6736(07)60028-2
17 https://doi.org/10.1016/s0959-8049(01)00267-2
18 https://doi.org/10.1016/s1470-2045(11)70033-x
19 https://doi.org/10.1016/s1470-2045(12)70472-2
20 https://doi.org/10.1016/s1470-2045(12)70482-5
21 https://doi.org/10.1017/s0266462315000094
22 https://doi.org/10.1056/nejmoa052306
23 https://doi.org/10.1080/02841860601096841
24 https://doi.org/10.1080/13696998.2016.1185013
25 https://doi.org/10.1093/annonc/mdm185
26 https://doi.org/10.1093/annonc/mdm488
27 https://doi.org/10.1200/jco.2005.02.4091
28 https://doi.org/10.1200/jco.2006.06.3081
29 https://doi.org/10.1200/jco.2006.06.4220
30 https://doi.org/10.1200/jco.2006.09.1611
31 https://doi.org/10.1200/jco.2008.21.4577
32 https://doi.org/10.1200/jco.2018.36.15_suppl.506
33 https://doi.org/10.1200/jgo.2015.003079
34 https://doi.org/10.1200/jgo.2016.004945
35 https://doi.org/10.1200/jgo.2016.006072
36 https://doi.org/10.1200/jgo.2016.008672
37 https://doi.org/10.12688/gatesopenres.12786.1
38 https://doi.org/10.1590/s1135-57272004000300012
39 https://doi.org/10.18632/oncotarget.16985
40 https://doi.org/10.18773/austprescr.2017.014
41 https://doi.org/10.2471/blt.15.164418
42 https://doi.org/10.5539/gjhs.v7n1p98
43 https://doi.org/10.7705/biomedica.v33i3.832
44 schema:datePublished 2019-12
45 schema:datePublishedReg 2019-12-01
46 schema:description Background: Breast cancer is the second most common cancer worldwide, the most common among women, and the most frequent cause of death among women in less developed regions. Trastuzumab is a humanized monoclonal antibody that downregulates the extracellular domain of the HER2 protein. Using trastuzumab to treat women with localized HER2-positive breast cancer has been shown to improve survival. The objective of this study is to explore the cost-effectiveness of adjuvant trastuzumab, from a societal perspective, in 11 African countries. In addition, we aimed to establish value-based prices for trastuzumab based on the gross domestic product per capita in each country. Methods: We developed a Markov model in order to assess the costs and benefits associated with trastuzumab treatment over a lifetime horizon. A probabilistic sensitivity analysis was performed in order to estimate the impact of uncertainty of parameter-values on the results. Efficacy inputs were derived using clinical trial data from non-African countries. Results: In the base case analysis, trastuzumab yielded a gain ranging from 0.92 LYs in Nigeria to 1.07 LYs in South Africa, and 0.9 QALYs in Nigeria to 1.02 QALYs in South Africa. The incremental cost ranged from 19,561 USD in Nigeria to 19,997 USD in Congo, and an incremental cost-effectiveness ratio ranging from 19,534 USD/QALY in South Africa to 21,697 USD/QALY in Nigeria. Using willingness to pay estimates based on World Health Organization recommendations, trastuzumab appear to not be cost-effective in all countries analyzed. Cost-effectiveness estimates were most sensitive to the discount rate, trastuzumab cost, and the hazard ratio. Conclusions: Trastuzumab does not appear to be cost effective in the African countries analyzed. In order for trastuzumab to be cost-effective, the costs of treatment would require significant discounts.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree true
50 schema:isPartOf Ndec647a3ba0b4bfdb62052be9c43b300
51 Nf696471ec5ed4a6e93f15b756e22ac13
52 sg:journal.1032048
53 schema:name Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer
54 schema:pagination 5
55 schema:productId N200f3aa62c004a24b2531086aaf50d3d
56 N5c85ee56089b4e56b66f8e784b2302c4
57 N728ec96281434efbbeceb372eb278022
58 N859819e0bf434e2a9550de85c6be6fb4
59 Nfaebbab95980468fb122a492f7602b7e
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112461724
61 https://doi.org/10.1186/s12962-019-0174-7
62 schema:sdDatePublished 2019-04-11T13:19
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N0676744087294c738362a6dd3b5d5435
65 schema:url https://link.springer.com/10.1186%2Fs12962-019-0174-7
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N0676744087294c738362a6dd3b5d5435 schema:name Springer Nature - SN SciGraph project
70 rdf:type schema:Organization
71 N200f3aa62c004a24b2531086aaf50d3d schema:name pubmed_id
72 schema:value 30867655
73 rdf:type schema:PropertyValue
74 N37970be5e0334631979e1e8f3973b83c rdf:first N6dbe1036a81b4e4d985178ef5dd1b610
75 rdf:rest Nca7dd05d2d554a7cb46afdd98a8ee5b0
76 N3d8e022d53fe426bb4f354e3e8b8e692 rdf:first Nc972a236a4c347ed8902691f3e996a40
77 rdf:rest Nd503841a395546ffb38ba2a257745f98
78 N5c85ee56089b4e56b66f8e784b2302c4 schema:name doi
79 schema:value 10.1186/s12962-019-0174-7
80 rdf:type schema:PropertyValue
81 N6dbe1036a81b4e4d985178ef5dd1b610 schema:affiliation https://www.grid.ac/institutes/grid.417068.c
82 schema:familyName Hall
83 schema:givenName Peter S.
84 rdf:type schema:Person
85 N728ec96281434efbbeceb372eb278022 schema:name dimensions_id
86 schema:value pub.1112461724
87 rdf:type schema:PropertyValue
88 N859819e0bf434e2a9550de85c6be6fb4 schema:name readcube_id
89 schema:value 895c986a331129a899509a6ba509a427fa8dc5b52e7f4d087fcdd50bce8e7c7b
90 rdf:type schema:PropertyValue
91 Nc73ec07120d14499a7e383b3ab53ab41 schema:affiliation https://www.grid.ac/institutes/grid.410711.2
92 schema:familyName Goldstein
93 schema:givenName Daniel A.
94 rdf:type schema:Person
95 Nc972a236a4c347ed8902691f3e996a40 schema:affiliation https://www.grid.ac/institutes/grid.7489.2
96 schema:familyName Gershon
97 schema:givenName Noga
98 rdf:type schema:Person
99 Nca7dd05d2d554a7cb46afdd98a8ee5b0 rdf:first Nc73ec07120d14499a7e383b3ab53ab41
100 rdf:rest rdf:nil
101 Nd503841a395546ffb38ba2a257745f98 rdf:first Nf781fc29b797489cb3728e5869527b70
102 rdf:rest N37970be5e0334631979e1e8f3973b83c
103 Ndec647a3ba0b4bfdb62052be9c43b300 schema:volumeNumber 17
104 rdf:type schema:PublicationVolume
105 Nf696471ec5ed4a6e93f15b756e22ac13 schema:issueNumber 1
106 rdf:type schema:PublicationIssue
107 Nf781fc29b797489cb3728e5869527b70 schema:affiliation https://www.grid.ac/institutes/grid.7489.2
108 schema:familyName Berchenko
109 schema:givenName Yakir
110 rdf:type schema:Person
111 Nfaebbab95980468fb122a492f7602b7e schema:name nlm_unique_id
112 schema:value 101170476
113 rdf:type schema:PropertyValue
114 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
115 schema:name Economics
116 rdf:type schema:DefinedTerm
117 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
118 schema:name Applied Economics
119 rdf:type schema:DefinedTerm
120 sg:journal.1032048 schema:issn 1478-7547
121 schema:name Cost Effectiveness and Resource Allocation
122 rdf:type schema:Periodical
123 sg:pub.10.1007/s40273-017-0557-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091117104
124 https://doi.org/10.1007/s40273-017-0557-6
125 rdf:type schema:CreativeWork
126 sg:pub.10.1186/s12905-018-0531-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101044352
127 https://doi.org/10.1186/s12905-018-0531-2
128 rdf:type schema:CreativeWork
129 sg:pub.10.1186/s13027-017-0124-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1083812371
130 https://doi.org/10.1186/s13027-017-0124-y
131 rdf:type schema:CreativeWork
132 sg:pub.10.2165/00019053-200725050-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003711819
133 https://doi.org/10.2165/00019053-200725050-00006
134 rdf:type schema:CreativeWork
135 sg:pub.10.2165/11588340-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011962935
136 https://doi.org/10.2165/11588340-000000000-00000
137 rdf:type schema:CreativeWork
138 https://app.dimensions.ai/details/publication/pub.1078418950 schema:CreativeWork
139 https://doi.org/10.1001/jamaoncol.2018.1380 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104331312
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1002/cncr.22806 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002193019
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1002/ijc.29210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018963471
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1016/j.breast.2014.06.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048566187
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1016/j.jval.2016.02.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031786311
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1016/j.jval.2016.09.821 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043954092
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1016/s0140-6736(07)60028-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002898249
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1016/s0959-8049(01)00267-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019983042
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/s1470-2045(11)70033-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1021985398
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/s1470-2045(12)70472-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052501236
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/s1470-2045(12)70482-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038280023
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1017/s0266462315000094 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018482864
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1056/nejmoa052306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014794593
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1080/02841860601096841 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025960991
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1080/13696998.2016.1185013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041930821
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1093/annonc/mdm185 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031056137
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1093/annonc/mdm488 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016825538
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1200/jco.2005.02.4091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024439769
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1200/jco.2006.06.3081 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018859926
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1200/jco.2006.06.4220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019914471
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1200/jco.2006.09.1611 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013648680
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1200/jco.2008.21.4577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036202282
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1200/jco.2018.36.15_suppl.506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106715249
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1200/jgo.2015.003079 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204594
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1200/jgo.2016.004945 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004733479
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1200/jgo.2016.006072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083942084
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1200/jgo.2016.008672 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085401969
192 rdf:type schema:CreativeWork
193 https://doi.org/10.12688/gatesopenres.12786.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100468989
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1590/s1135-57272004000300012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068110095
196 rdf:type schema:CreativeWork
197 https://doi.org/10.18632/oncotarget.16985 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092572143
198 rdf:type schema:CreativeWork
199 https://doi.org/10.18773/austprescr.2017.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084374293
200 rdf:type schema:CreativeWork
201 https://doi.org/10.2471/blt.15.164418 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070838422
202 rdf:type schema:CreativeWork
203 https://doi.org/10.5539/gjhs.v7n1p98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072947815
204 rdf:type schema:CreativeWork
205 https://doi.org/10.7705/biomedica.v33i3.832 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073857235
206 rdf:type schema:CreativeWork
207 https://www.grid.ac/institutes/grid.410711.2 schema:alternateName University of North Carolina System
208 schema:name Davidoff Cancer Center, Rabin Medical Center, Petach Tikvah, Israel
209 Department of Health Policy and Management, University of North Carolina, Chapel Hill, USA
210 rdf:type schema:Organization
211 https://www.grid.ac/institutes/grid.417068.c schema:alternateName Western General Hospital
212 schema:name Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK
213 rdf:type schema:Organization
214 https://www.grid.ac/institutes/grid.7489.2 schema:alternateName Ben-Gurion University of the Negev
215 schema:name Ben-Gurion University of the Negev, P.O.B. 653, 8410501, Beer-Sheva, Israel
216 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...